B., Albayaty, M., Breitschaft, A., et al
Our personalized approach ensures that each client receives a tailored treatment plan that addresses their unique needs and goals
Role of amylin in glucose homeostasis
For CT-388, these findings offer an inference but not a guarantee
The LIRA-RENAL Trial (Once-Daily Liraglutide) The Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL) trial investigated the efficacy and safety of liraglutide as an add-on to existing glucose-lowering medications in people with inadequately controlled T2DM and moderate renal impairment (stage 3 CKD, eGFR 3059 ml/min/1.73 m 2 ) [48]
Bai Y, Guo J, Reiter RJ, Wei Y, Shi H